Delivery Order SPE2DB20D2014-SPE2DB25FB86Q
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Yonsa 125 mg tablets (120-count units) valued at $2,271.36 with a firm fixed price structure. The order is scheduled for completion by May 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a ceiling value of $4,787.34. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by January 21, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Yonsa 125 mg tablets (120-count units) with a contract ceiling value of $4,542.74 and a firm fixed price structure. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by July 2, 2025. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.36 to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Yonsa 125 mg tablets (120-count units). This is a firm fixed-price delivery order with an ultimate completion date of June 11, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a ceiling value of $4,542.74. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is to be completed by September 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Yonsa 125 mg tablets (120 count) with a firm fixed price of $2,271.36 and an ultimate completion date of October 16, 2025. This is a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Yonsa (125 mg tablets, 120-count package) under a firm fixed-price contract with a ceiling value of $2,393.67 and an ultimate completion date of January 13, 2026. This competitive, non-set-aside award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Yonsa 125 mg tablets in quantities of 120 units. This competitively awarded, non-set-aside contract carries a ceiling value of $19,149.36 and is structured as a firm fixed price delivery order, with an ultimate completion date of January 9, 2026. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $4,787.34 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Yonsa 125 mg tablets (120-count). This is a non-set-aside, competitively awarded contract with firm fixed pricing and a completion date of December 19, 2025. The pharmaceutical will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,271.36 delivery order to AmerisourceBergen Drug Corp for Yonsa 125 mg tablets (120-count supply) with an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This delivery order falls...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB86QDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Yonsa 125 mg tablets (120-count package) valued at $2,271.36 with a firm fixed price structure. This delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The contractor's place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of May 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, medical supplies, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Yonsa, a prescription oncology medication, exemplifies the company's role in fulfilling the Defense Health Agency's pharmaceutical supply requirements through the DLA's streamlined delivery order process under its broader prime vendor contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/6/25 |